Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
3.49
-0.27 (-7.18%)
At close: Aug 18, 2025, 3:59 PM
3.47
-0.57%
After-hours: Aug 18, 2025, 07:14 PM EDT
Immuneering Revenue
Immuneering reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Immuneering generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
54
Market Cap
125.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | -100.00% |
| Dec 31, 2022 | 316.95K | -84.76% |
| Dec 31, 2021 | 2.08M | -10.02% |
| Dec 31, 2020 | 2.31M | +20.41% |
| Dec 31, 2019 | 1.92M | n/a |